A novel case of neonatal severe hyperparathyroidism successfully treated with a type II calcimimetic drug

We report a boy with hypercalcemia due to neonatal severe hyperparathyroidism (NSHPT) caused by a compound heterozygous mutation in the calcium sensing receptor (CaSR) managed successfully on a type II calcimimetic drug. The hypercalcemia was temporarily treated by hyperhydration, bisphosphonate and...

ver descrição completa

Detalhes bibliográficos

Principais autores:	T.L. Leunbach, A.T. Hansen, M. Madsen, R. Cipliene, P.S. Christensen, A.J. Schou
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2021-06-01
Colecção:	Bone Reports
Assuntos:	Neonatal severe hyperparathyroidism Symptomatic hypercalcemia Compound heterozygosity Type II calcimimetics
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2352187221000164
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!